Search research articles
Contact Us
Filters
Showing results (181-190 of 393) with videos related to
Page
of 40
Sort By:
Frontiers in Pharmacology
|
October 13, 2022
KIF20A is associated with clinical prognosis and synergistic effect of gemcitabine combined with ferroptosis inducer in lung adenocarcinoma
Hua He, Lu Liang, Jingjing Huang, et al.
Pharmacogenomics and Personalized Medicine
|
April 3, 2023
RUNX2 Reverses p53-Induced Chemotherapy Resistance in Gastric Cancer
Yuan Huang, Lu Liang, Yong-Xiang Zhao, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
February 5, 2024
GSK3β: A ray of hope for the treatment of diabetic kidney disease
Lu-Lu Liang, Meng-Fei He, Pan-Pan Zhou, et al.
Polymers
|
April 10, 2019
Solubility Difference between Pectic Fractions from Creeping Fig Seeds
Ri-Si Wang, Xiao-Hong He, Hong Lin, et al.
International Journal of Molecular Sciences
|
September 23, 2022
<i>TIAM2</i> Contributes to Osimertinib Resistance, Cell Motility, and Tumor-Associated Macrophage M2-like Polarization in Lung Adenocarcinoma
Lu Liang, Hua He, Shiyao Jiang, et al.
Toxicology Letters
|
March 29, 2013
Cajaninstilbene acid (CSA) exerts cytoprotective effects against oxidative stress through the Nrf2-dependent antioxidant pathway
Lu Liang, Meng Luo, Yujie Fu, et al.
Hypertension (Dallas, Tex. : 1979)
|
February 24, 2001
Effects of Blood Pressure, Smoking, and Their Interaction on Carotid Artery Structure and Function
Yu-Lu Liang, Louise M. Shiel, Helena Teede, et al.
Chinese Medical Journal
|
February 21, 2013
Association between the rate of the morning surge in blood pressure and cardiovascular events and stroke
Yu Luo, Yan-li Wang, Ying-biao Wu, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
August 26, 2015
Downregulation of MiR-30a is Associated with Poor Prognosis in Lung Cancer
Ruixue Tang, Lu Liang, Dianzhong Luo, et al.
Oncotargets and Therapy
|
October 4, 2016
Clinical comparative investigation of efficacy and toxicity of cisplatin plus gemcitabine or plus Abraxane as first-line chemotherapy for stage III/IV non-small-cell lung cancer
Dan Ai, Yan Guan, Xiu-Ju Liu, et al.
Page
of 40
Search research articles
Search
Showing results (181-190 of 393) with videos related to
Sort By:
Page
of 40
Frontiers in Pharmacology
|
October 13, 2022
KIF20A is associated with clinical prognosis and synergistic effect of gemcitabine combined with ferroptosis inducer in lung adenocarcinoma
Hua He, Lu Liang, Jingjing Huang, et al.
Pharmacogenomics and Personalized Medicine
|
April 3, 2023
RUNX2 Reverses p53-Induced Chemotherapy Resistance in Gastric Cancer
Yuan Huang, Lu Liang, Yong-Xiang Zhao, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
February 5, 2024
GSK3β: A ray of hope for the treatment of diabetic kidney disease
Lu-Lu Liang, Meng-Fei He, Pan-Pan Zhou, et al.
Polymers
|
April 10, 2019
Solubility Difference between Pectic Fractions from Creeping Fig Seeds
Ri-Si Wang, Xiao-Hong He, Hong Lin, et al.
International Journal of Molecular Sciences
|
September 23, 2022
<i>TIAM2</i> Contributes to Osimertinib Resistance, Cell Motility, and Tumor-Associated Macrophage M2-like Polarization in Lung Adenocarcinoma
Lu Liang, Hua He, Shiyao Jiang, et al.
Toxicology Letters
|
March 29, 2013
Cajaninstilbene acid (CSA) exerts cytoprotective effects against oxidative stress through the Nrf2-dependent antioxidant pathway
Lu Liang, Meng Luo, Yujie Fu, et al.
Hypertension (Dallas, Tex. : 1979)
|
February 24, 2001
Effects of Blood Pressure, Smoking, and Their Interaction on Carotid Artery Structure and Function
Yu-Lu Liang, Louise M. Shiel, Helena Teede, et al.
Chinese Medical Journal
|
February 21, 2013
Association between the rate of the morning surge in blood pressure and cardiovascular events and stroke
Yu Luo, Yan-li Wang, Ying-biao Wu, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
August 26, 2015
Downregulation of MiR-30a is Associated with Poor Prognosis in Lung Cancer
Ruixue Tang, Lu Liang, Dianzhong Luo, et al.
Oncotargets and Therapy
|
October 4, 2016
Clinical comparative investigation of efficacy and toxicity of cisplatin plus gemcitabine or plus Abraxane as first-line chemotherapy for stage III/IV non-small-cell lung cancer
Dan Ai, Yan Guan, Xiu-Ju Liu, et al.
Page
of 40